VS
Venkata Subbarao
About Venkata Subbarao
Data last updated:
Venkata Subbarao is a Director at Dexbio Pharma Private Limited (since 2006), Director at Neomediispecs Private Limited (since 2017) and Designated Partner at Sri Vigneshwara Printers Llp (since 2022), and holds 1 more current directorship. The companies operate in Pharma, FMCG and Packaging. The 2 current companies with reported revenue have a combined latest revenue of ₹42.02 Cr; the largest is Dexbio Pharma Private Limited at ₹21.52 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Dexbio Pharma Private Limited U24232UR2006PTC011840 | Director | 23 Aug 2006 | 2006 | ₹21.52 Cr (FY 2025) | Active |
| Neomediispecs Private Limited U74999TN2017PTC117758 | Director | 25 Jul 2017 | 2017 | ₹20.50 Cr (FY 2025) | Active |
| Sri Vigneshwara Printers Llp ABA-3535 | Designated Partner | 24 Jan 2022 | 2022 | Active | |
| Dexbio Life Sciences Private Limited U24304PY2016PTC008119 | Director | 16 Dec 2016 | 2016 | Active |
Board colleagues of Venkata Subbarao
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anshul Chhabra | 08070427 | Dexbio Pharma Private Limited | Director |
| Rajeev Kumar Chhabra | 00935360 | Dexbio Pharma Private Limited | Director |
| Venkata Rangaiah Kothuri | 01925729 | Dexbio Pharma Private Limited , Dexbio Life Sciences Private Limited | Director |
| Rajeswari Chaluvadi | 07873548 | Neomediispecs Private Limited , Sri Vigneshwara Printers Llp | Director |
| Kothuri Saraswathi | 07826203 | Dexbio Life Sciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Venkata Subbarao
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Venkata Subbarao
Venkata Subbarao currently holds 4 directorships: Dexbio Pharma Private Limited (Director, since 23 Aug 2006, revenue ₹21.52 Cr (FY 2025)); Neomediispecs Private Limited (Director, since 25 Jul 2017, revenue ₹20.50 Cr (FY 2025)); Sri Vigneshwara Printers Llp (Designated Partner, since 24 Jan 2022); Dexbio Life Sciences Private Limited (Director, since 16 Dec 2016).
Venkata Subbarao was first appointed on 23 Aug 2006 as Director at Dexbio Pharma Private Limited. The most recent appointment on record is 24 Jan 2022 at Sri Vigneshwara Printers Llp.
The 2 current companies of Venkata Subbarao that report revenue have a combined latest revenue of ₹42.02 Cr: Dexbio Pharma Private Limited ₹21.52 Cr (FY 2025); Neomediispecs Private Limited ₹20.50 Cr (FY 2025).
The current boards of Venkata Subbarao's companies include Anshul Chhabra (Dexbio Pharma Private Limited), Rajeev Kumar Chhabra (Dexbio Pharma Private Limited), Venkata Rangaiah Kothuri (Dexbio Pharma Private Limited), Rajeswari Chaluvadi (Neomediispecs Private Limited), Kothuri Saraswathi (Dexbio Life Sciences Private Limited).